Advocating for Change for Adolescents! A Practical Toolkit for Young People to Advocate for Improved Adolescent Health and Wellbeing. WHO. (2017)

image

This toolkit was developed by young people, for young people, to be used by networks of youth-led and youth-serving organizations to change the world! The toolkit will also be useful for others, including civil society groups, government departments and everyone concerned with adolescent health and well-being. The purpose of this toolkit is to guide the design, implementation and monitoring of an effective national advocacy action roadmap to bring about positive policy-specific changes to improve the health and well-being of adolescents.

 

Keywords: health, advocacy, national policies, strategies and plans

 

Download Toolkit

Consolidated Guideline on Sexual and Reproductive Health and Rights of Women Living with HIV - Executive Summary. WHO. (2017)

image

This guideline responds to requests from organizations, institutions and individuals for guidance which consolidates existing recommendations specific to women living with HIV along with new recommendations and good practice statements. It is expected to support front-line health-care providers, programme managers and public health policy-makers around the world to better address the sexual and reproductive health and rights (SRHR) of women living with HIV.


Keywords: HIV, gender, human rights, health care, good practice

 

Download Executive Summary

Consolidated Guideline on Sexual and Reproductive Health and Rights of Women Living with HIV. WHO. (2017)

image

This guideline is meant to help countries to more effectively and efficiently plan, develop and monitor programmes and services that promote gender equality and human rights and hence are more acceptable and appropriate for women living with HIV, taking into account the national and local epidemiological context. It discusses implementation issues that health interventions and service delivery must address to achieve gender equality and support human rights.

 

Keywords: HIV, gender, human rights, health care, good practice

 

Download Full Report and Executive Summary

Consolidated Guidelines on Person-centred HIV Patient Monitoring and Case Surveillance. WHO. (2017)

image

These guidelines consolidate guidance on monitoring systems for patients and all cases of HIV as part of public health surveillance. They recommend the use of unique identifiers to link patients across health services, allowing the sustainable measurement of the cascade of services. The guidelines promote the use of routine data for patient care and enable reporting on most programme, national and global indicators, including key global targets for HIV. 


Keywords: HIV, data, monitoring system

 


Download Consolidated Guidelines and Technical Brief

Gender Analysis Toolkit for Key Population HIV Prevention, Care and Treatment Programs. FHI 360/LINKAGES. (2017)

image

This toolkit provides practical guidance to governments, funders, civil society organizations and other implementing partners on conducting a gender analysis and using findings to inform HIV prevention, care and treatment programs with key populations. It outlines considerations and steps for conducting a gender analysis; explores how to engage with stakeholders, including key population members, in a meaningful partnership; shares lessons learned from a comprehensive gender analysis in Kenya and an abridged gender analysis in Cameroon; and provides tools and resources for conducting a gender analysis with key populations.


Keywords: MSM, PWID, SW, gender, prevention, health care, treatment

 

Download Publication

Guidelines for the Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. WHO. (2017)

image

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV. 

 


Keywords: HIV, ART, diagnosis, treatment, vaccination

 


Download Guidelines and Annexes

Guidelines for Treatment of Drug-susceptible Tuberculosis and Patient Care (2017 Update). WHO. (2017)

image

The WHO Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update) contains policy recommendations on priority areas in the treatment of drug-susceptible TB and patient care. The main highlights of the guidelines are:

- The category II regimen is no longer recommended for patients who require TB retreatment and drug-susceptibility testing should be conducted to inform the choice of treatment regimen;
- The use of adjuvant steroids is recommended in the treatment of tuberculous meningitis and pericarditis;
- Recommendations on the provision of individual or a package of interventions on patient care and support, including patient or staff education, material support, psychological support, and tracers.


Keywords: HIV, TB, ART, treatment, care and support

 

Download Guidelines 

Guidelines on Hepatitis B and C Testing. WHO. (2017)

image

Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviours and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination. 


Keywords: HIV, HBV, HCV, infection, treatment, prevention

 

Download Document

Guidelines on the Public Health Response to Pretreatment HIV Drug Resistance. WHO. (2017)

image

This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral (ARV) drug exposure or people with prior ARV exposure who are initiating or reinitiating first-line antiretroviral therapy (ART).

It also provides the consensus prevalence or threshold of pretreatment HIVDR to NNRTIs at which specific public health actions are triggered. This publication is a supplement to Chapter 4 of the 2016 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2016 WHO consolidated ARV guidelines).

 

Keywords: HIVDR, ART, treatment, response, drug resistance

 

Download Publication

HIV and Social Protection Assessment Tool: Generating Evidence for Policy and Action on HIV and Social Protection. UNAIDS. (2017)

image

The HIV and social protection assessment tool is used for a quick scan of existing social protection programmes and their sensitivity (or lack of) to the HIV response in a given country and location. Additional follow-up and research that engages the different critical actors, including HIV programme managers, social protection administrators, beneficiaries and civil society representatives, may be necessary in some contexts. The assessment provides countries and communities with tailored analysis on HIV and social protection.


Keywords: HIV, data, tools, assessment

 

Download Document

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_July-Oct-AIDSreg2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_Report_Punjab_2014_0.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/The_negative_impact_of_drug_control_on_public_health_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Death_Penalty_for_Drug_Offences_Global_Overview_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Consolidated_Strategic_Information_Guidelines_for_HIV_in_Health_Sector_2015.pdf
Calendar of events
Jul
28
(28 Jul - 28 Jul)
Aug
12
(12 Aug - 12 Aug)